This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

'Fast Money' Recap: Navigating a Holding Pattern

The trading panel on CBNC's "Fast Money" TV show discussed some survival tactics on another dark market session on Monday.

The Dow Jones Industrial Average plunged 250.89, or 3.41%, to 7,114.48, while the S&P 500 fell 26.72, or 3.47%, to 743.33. The Nasdaq dropped 53.51, or 3.71%, to 1,387.72.

Dylan Ratigan, the moderator of the show, asked the panel to focus on what trading strategies they would make in the interim while waiting for the market to recover.

Pete Najarian told viewers not to attempt to buy the bottom of anything. He said he's stayed away from the banking sector except for some of the names the panel has liked such as Morgan Stanley (MS - Get Report).

Tim Seymour said he was trading "light." "You can't really manage a portfolio" under these circumstances, he said.

Ratigan asked Adami what to make of General Electric (GE - Get Report) dipping below $8. Adami said the negative number must be coming from its financial arm because GE's infrastructure business alone is worth at least $9. He said the company probably deserves that valuation because it is doing poorly in real estate.

Karen Finerman agreed, noting the company has a huge lending book and is bogged down by a financial business that is intertwined with its other businesses.

Seymour said he found it unbelievable that the stock is yielding 14%. "It's not supposed to do that," he said.

Ratigan moved on to a healthy side of the market: the pharmaceuticals, biotech and medical devices. Najarian noted that the rejection of bids by CV Therapeutics (CVTX) and Genentech (DNA) underscores the amount of cash in this sector and the opportunities for growth.
1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
FDO $79.39 0.05%
GE $23.88 -3.79%
MS $33.12 -3.86%
PZE $5.38 -4.27%
RIO $34.32 -6.54%

Markets

Chart of I:DJI
DOW 16,058.35 -469.68 -2.84%
S&P 500 1,913.85 -58.33 -2.96%
NASDAQ 4,636.1050 -140.4030 -2.94%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs